Business Update

Cinvention, Relisys Medical extend agreement for non-eluting coronary stent

Published in Health Business Week, February 2nd, 2007

Cinvention announced the extension of the existing License and Supply Agreement with Relisys Medical for the manufacturing, global marketing and sales of a non-eluting coronary stent with a bioactive nano-structured carbon-composite coating with pro-healing properties.

Relisys' new stent consists of a Cobalt-Chromium Stent, coated with a porous carbon/carbon composite nano-structured matrix with a surface design for improved endothelialization. Relisys' chairman N. Krishna Reddy said this version of a coronary stent has the potential to overcome certain concerns with current Drug-Eluting Stents substantially. Krishna Reddy pointed out that the animal study results at...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2007-02-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry